Amarin Corp. ADR Stock
Price
Target price
-
-
-
-
-
?8.24
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Amarin Corp. ADR Stock
The community sentiment towards Amarin Corp. ADR is currently rather negative with 6 Sell predictions and no Buy predictions.
However, we have a potential of 1860.78% for Amarin Corp. ADR as the target price of 8 € is above the current price of 0.41 €.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Amarin Corp. ADR stock. Negative votes have not been in the majority for any criteria for this stock
Amarin Corporation plc (Symbol AMRN) is a biopharmaceutical company that is focused on the development and commercialization of therapeutics to improve cardiovascular health. The company's main product, Vascepa, is a prescription medication that has been approved by the US FDA for use as an adjunct to diet to reduce triglyceride levels in adults with severe hypertriglyceridemia. Vascepa has also shown to reduce the risk of cardiovascular events such as heart attack and stroke in patients with elevated cardiovascular risk. As a listed company, Amarin is publicly traded on the NASDAQ stock exchange and has a market capitalization of approximately $5 billion as of August 2021.
Pros and Cons of Amarin Corp. ADR in the next few years
Pros
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Cons
?
B****
?
C******** o* t** e**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Amarin Corp. ADR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Amarin Corp. ADR | - | - | - | - | - | - | - |
| Genus plc | -0.690% | 8.333% | -10.063% | 17.213% | 59.777% | -0.694% | -32.738% |
| Novocure Ltd | 1.480% | 10.395% | 16.086% | -8.709% | -58.242% | -85.435% | -88.741% |
| Ironwood Pharmaceuticals | 0.000% | 8.475% | 31.959% | -64.045% | -69.524% | -87.607% | -84.578% |
Comments
Amarin Corporation PLC (NASDAQ: AMRN) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $7.00 to $12.00. They now have a "sell" rating on the stock.
Show more
Ratings data for AMRN provided by MarketBeat
Amarin Co. plc (NASDAQ: AMRN) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $20.00 to $7.00. They now have a "sell" rating on the stock.
Show more
Ratings data for AMRN provided by MarketBeat
Amarin Co. plc (NASDAQ: AMRN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for AMRN provided by MarketBeat
